Citation
Dal Picolo, Camilla R., et al. "Antileishmanial Activity Evaluation of Adunchalcone, a New Prenylated Dihydrochalcone From Piper Aduncum L." Fitoterapia, vol. 97, 2014, pp. 28-33.
Dal Picolo CR, Bezerra MP, Gomes KS, et al. Antileishmanial activity evaluation of adunchalcone, a new prenylated dihydrochalcone from Piper aduncum L. Fitoterapia. 2014;97:28-33.
Dal Picolo, C. R., Bezerra, M. P., Gomes, K. S., Passero, L. F., Laurenti, M. D., Martins, E. G., Sartorelli, P., & Lago, J. H. (2014). Antileishmanial activity evaluation of adunchalcone, a new prenylated dihydrochalcone from Piper aduncum L. Fitoterapia, 97, 28-33. https://doi.org/10.1016/j.fitote.2014.05.009
Dal Picolo CR, et al. Antileishmanial Activity Evaluation of Adunchalcone, a New Prenylated Dihydrochalcone From Piper Aduncum L. Fitoterapia. 2014;97:28-33. PubMed PMID: 24862066.
TY - JOUR
T1 - Antileishmanial activity evaluation of adunchalcone, a new prenylated dihydrochalcone from Piper aduncum L.
AU - Dal Picolo,Camilla R,
AU - Bezerra,Mariana P,
AU - Gomes,Kaio S,
AU - Passero,Luiz Felipe D,
AU - Laurenti,Marcia D,
AU - Martins,Euder Glendes A,
AU - Sartorelli,Patricia,
AU - Lago,João Henrique G,
Y1 - 2014/05/24/
PY - 2014/03/07/received
PY - 2014/05/15/revised
PY - 2014/05/16/accepted
PY - 2014/5/28/entrez
PY - 2014/5/28/pubmed
PY - 2015/4/22/medline
KW - Adunchalcone
KW - Antileishmanial
KW - Dihydrochalcone
KW - Piper aduncum
KW - Piperaceae
SP - 28
EP - 33
JF - Fitoterapia
JO - Fitoterapia
VL - 97
N2 - Bioactivity-guided fractionation of EtOH extract from the leaves of Piper aduncum L. (Piperaceae) afforded a new dihydrochalcone, named adunchalcone. Its structure was elucidated on the basis of their spectroscopic data, primarily NMR and MS. Adunchalcone was evaluated against promastigote forms of Leishmania (L.) amazonensis, L. (V.) braziliensis, L. (V.) shawi, and L. (L.) chagasi and displayed 50% effective concentrations (EC50) of 11.03, 26.70, and 11.26 μM, as well as selective indexes of 4.86, 2.01, 4.76 and 0.50, respectively. This compound was also tested against intracellular forms of L. (L.) amazonensis, displaying weak activity, in comparison to reference drug amphotericin B. However, despite reduced effect of adunchalcone against amastigotes of L. (L.) amazonensis, this work opens the perspective to use this particular molecule as a scaffold for the design of novel and selective drug candidates for neglected diseases, mainly leishmaniasis.
SN - 1873-6971
UR - https://www.unboundmedicine.com/medline/citation/24862066/Antileishmanial_activity_evaluation_of_adunchalcone_a_new_prenylated_dihydrochalcone_from_Piper_aduncum_L_
DB - PRIME
DP - Unbound Medicine
ER -